It is a trading private limited company based in Delhi, Delhi, India, established in 2019.
2019 | Delhi, Delhi, India | ActiveSpanmed Pharmaceuticals Private Limited, a active private limited company, was established on 04 January 2019 in Delhi, Delhi, India. Engaging in specialty within the trading sector, it holds CIN: U51909DL2019PTC343811. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Richard Francis Koli (Director), Sushil Sudam Salvi (Director). Past directors included Raj Kumar Meghwanshi, Manish Khanna, Dayawati. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No.-46, Pocket G-28 Sector-3 Rohini, Delhi, Delhi, 110085.
U51909DL2019PTC343811
343811
04 January 2019
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Spanmed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Richard Francis Koli | Director | 03 Oct 2023 | Current |
| Sushil Sudam Salvi | Director | 27 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Oct 2023 | Past |
| Pramod Abcsdd | Director | 17 Oct 2023 | Past |
| Pramod Abcsdd | Director | 17 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spanmed Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 75.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Spanmed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Spanmed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Spanmed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spanmed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sushil Sudam Salvi was appointed as a Director was appointed as a Director on 27 Nov 2024 & has been associated with this company since 1 year 4 days . was recorded as a recent event.
The activity Spanmed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Spanmed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Richard Francis Koli was appointed as a Director was appointed as a Director on 03 Oct 2023 & has been associated with this company since 2 years 2 months . was documented.
Progress on Spanmed Pharmaceuticals Private Limited was registered on 04 Jan 2019 with Roc Delhi & aged 6 years 10 months as per MCA records. was documented.
The CIN of Spanmed Pharmaceuticals Private Limited is U51909DL2019PTC343811.
Spanmed Pharmaceuticals Private Limited is headquartered at House No.-46, Pocket G-28 Sector-3 Rohini, Delhi, Delhi, 110085.
Spanmed Pharmaceuticals Private Limited was incorporated on 04 January 2019.
The current directors of Spanmed Pharmaceuticals Private Limited are
The primary industry of Spanmed Pharmaceuticals Private Limited is Trading.
Spanmed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Spanmed Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX